{"id":1142,"date":"2020-06-01T18:22:50","date_gmt":"2020-06-01T16:22:50","guid":{"rendered":"https:\/\/sonofirst-trial.eu\/publications_science\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\/"},"modified":"2020-06-01T18:22:50","modified_gmt":"2020-06-01T16:22:50","slug":"ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors","status":"publish","type":"publications_science","link":"https:\/\/sonofirst-trial.eu\/en\/publications_science\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\/","title":{"rendered":"Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors"},"content":{"rendered":"
\n
\n
Kevin Beccaria<\/a>\u00a0<\/span> 1 <\/a><\/sup>,\u00a0<\/span><\/span>Aria Sabbagh<\/a>\u00a0<\/span> 1 <\/a><\/sup>,\u00a0<\/span><\/span>John de Groot<\/a>\u00a0<\/span> 2 <\/a><\/sup>,\u00a0<\/span><\/span>Michael Canney<\/a>\u00a0<\/span> 3 <\/a><\/sup>,\u00a0<\/span><\/span>Alexandre Carpentier<\/a>\u00a0<\/span> 4 <\/a><\/sup>,\u00a0<\/span><\/span>Amy B Heimberger<\/a>\u00a0<\/span> 5 <\/a>\u00a0<\/span> 6 <\/a><\/sup><\/span><\/div>\n
\n
\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/32112296\/<\/a><\/strong><\/p>\n

Abstract<\/h2>\n
\n

Introduction: <\/strong> Opening of the blood-brain barrier (BBB) by pulsed low intensity ultrasound has been developed during the last decade and is now recognized as a safe technique to transiently and repeatedly open the BBB. This non- or minimally invasive technique allows for a targeted and uniform dispersal of a wide range of therapeutic substances throughout the brain, including immune cells and antibodies.<\/p>\n

Methods: <\/strong> In this review article, we summarize pre-clinical studies that have used BBB-opening by pulsed low intensity ultrasound to enhance the delivery of immune therapeutics and effector cell populations, as well as several recent clinical studies that have been initiated. Based on this analysis, we propose immune therapeutic strategies that are most likely to benefit from this strategy. The literature review and trial data research were performed using Medline\/Pubmed databases and clinical trial registry www.clinicaltrials.gov . The reference lists of all included articles were searched for additional studies.<\/p>\n

Results: <\/strong> A wide range of immune therapeutic agents, including small molecular weight drugs, antibodies or NK cells, have been safely and efficiently delivered to the brain with pulsed low intensity ultrasound in preclinical models, and both tumor control and increased survival have been demonstrated in different types of brain tumor models in rodents. Ultrasound-induced BBB disruption may also stimulate innate and cellular immune responses.<\/p>\n

Conclusions: <\/strong> Ultrasound BBB opening has just recently entered clinical trials with encouraging results, and the association of this strategy with immune therapeutics creates a new field of brain tumor treatment.<\/p>\n<\/div>\n

Keywords: <\/strong> Blood\u2013brain barrier; Drug delivery; Immunotherapy; Low intensity pulsed ultrasound.<\/p>\n

 <\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Kevin Beccaria\u00a0 1 ,\u00a0Aria Sabbagh\u00a0 1 ,\u00a0John de Groot\u00a0 2 ,\u00a0Michael Canney\u00a0 3 ,\u00a0Alexandre Carpentier\u00a0 4 ,\u00a0Amy B Heimberger\u00a0 5 […]<\/p>\n","protected":false},"featured_media":0,"template":"","projet_type":[6],"keywords":[],"class_list":["post-1142","publications_science","type-publications_science","status-publish","hentry","projet_type-sonofirst"],"acf":[],"yoast_head":"\nUltrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors - SonoFirst<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sonofirst-trial.eu\/en\/publications_science\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors - SonoFirst\" \/>\n<meta property=\"og:description\" content=\"Kevin Beccaria\u00a0 1 ,\u00a0Aria Sabbagh\u00a0 1 ,\u00a0John de Groot\u00a0 2 ,\u00a0Michael Canney\u00a0 3 ,\u00a0Alexandre Carpentier\u00a0 4 ,\u00a0Amy B Heimberger\u00a0 5 […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sonofirst-trial.eu\/en\/publications_science\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\/\" \/>\n<meta property=\"og:site_name\" content=\"SonoFirst\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sonofirst-trial.eu\\\/en\\\/publications_science\\\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\\\/\",\"url\":\"https:\\\/\\\/sonofirst-trial.eu\\\/en\\\/publications_science\\\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\\\/\",\"name\":\"Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors - SonoFirst\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sonofirst-trial.eu\\\/en\\\/#website\"},\"datePublished\":\"2020-06-01T16:22:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sonofirst-trial.eu\\\/en\\\/publications_science\\\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sonofirst-trial.eu\\\/en\\\/publications_science\\\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sonofirst-trial.eu\\\/en\\\/publications_science\\\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/sonofirst-trial.eu\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications scientifiques\",\"item\":\"https:\\\/\\\/sonofirst-trial.eu\\\/en\\\/publications_science\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sonofirst-trial.eu\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/sonofirst-trial.eu\\\/en\\\/\",\"name\":\"SonoFirst\",\"description\":\"supported by the European Union\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sonofirst-trial.eu\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors - SonoFirst","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sonofirst-trial.eu\/en\/publications_science\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\/","og_locale":"en_US","og_type":"article","og_title":"Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors - SonoFirst","og_description":"Kevin Beccaria\u00a0 1 ,\u00a0Aria Sabbagh\u00a0 1 ,\u00a0John de Groot\u00a0 2 ,\u00a0Michael Canney\u00a0 3 ,\u00a0Alexandre Carpentier\u00a0 4 ,\u00a0Amy B Heimberger\u00a0 5 […]","og_url":"https:\/\/sonofirst-trial.eu\/en\/publications_science\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\/","og_site_name":"SonoFirst","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/sonofirst-trial.eu\/en\/publications_science\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\/","url":"https:\/\/sonofirst-trial.eu\/en\/publications_science\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\/","name":"Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors - SonoFirst","isPartOf":{"@id":"https:\/\/sonofirst-trial.eu\/en\/#website"},"datePublished":"2020-06-01T16:22:50+00:00","breadcrumb":{"@id":"https:\/\/sonofirst-trial.eu\/en\/publications_science\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sonofirst-trial.eu\/en\/publications_science\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/sonofirst-trial.eu\/en\/publications_science\/ultrasound-induced-blood-brain-barrier-disruption-for-the-treatment-of-gliomas-and-other-primary-cns-tumors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/sonofirst-trial.eu\/en\/"},{"@type":"ListItem","position":2,"name":"Publications scientifiques","item":"https:\/\/sonofirst-trial.eu\/en\/publications_science\/"},{"@type":"ListItem","position":3,"name":"Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors"}]},{"@type":"WebSite","@id":"https:\/\/sonofirst-trial.eu\/en\/#website","url":"https:\/\/sonofirst-trial.eu\/en\/","name":"SonoFirst","description":"supported by the European Union","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sonofirst-trial.eu\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/sonofirst-trial.eu\/en\/wp-json\/wp\/v2\/publications_science\/1142","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sonofirst-trial.eu\/en\/wp-json\/wp\/v2\/publications_science"}],"about":[{"href":"https:\/\/sonofirst-trial.eu\/en\/wp-json\/wp\/v2\/types\/publications_science"}],"version-history":[{"count":0,"href":"https:\/\/sonofirst-trial.eu\/en\/wp-json\/wp\/v2\/publications_science\/1142\/revisions"}],"wp:attachment":[{"href":"https:\/\/sonofirst-trial.eu\/en\/wp-json\/wp\/v2\/media?parent=1142"}],"wp:term":[{"taxonomy":"projet_type","embeddable":true,"href":"https:\/\/sonofirst-trial.eu\/en\/wp-json\/wp\/v2\/projet_type?post=1142"},{"taxonomy":"keywords","embeddable":true,"href":"https:\/\/sonofirst-trial.eu\/en\/wp-json\/wp\/v2\/keywords?post=1142"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}